Not Yet RecruitingPhase 4ACTRN12610001018000
Misoprostol versus Oxytocin as prophylaxes against intraoperative and postoperative bleeding in cesarean section
Sponsor
Ain Shams University
Enrollment
220 participants
Start Date
Dec 1, 2010
Study Type
Interventional
Conditions
Summary
To compare the efficacy of rectally administrated Misoprostol vs. intravenous Oxytocin infusion during and after cesarean sections to control intraoperative and postoperative bleeding.
Eligibility
Sex: FemalesMin Age: 15 YearssMax Age: 45 Yearss
Inclusion Criteria1
- patients admitted for elective lower segment cesarean section
Exclusion Criteria1
- patients with risk factors for postpartum hemorrhage, emergency lower segment cesarean section, or known hypersensitivity to prostaglandins.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
600 microgram misoprostol (3 tablets) administrated rectally, right after induction of anesthesia.
600 microgram misoprostol (3 tablets) administrated rectally, right after induction of anesthesia.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12610001018000